Magnolia Medical Technologies News and Activities

View the org chart displaying its 15 main executives

Most searched biographies at Magnolia Medical Technologies

• Jason Richey, President and Chief Executive Officer
• Marc-André Marcotte, Director
• Paul Enever, Director

Popular executive movements at Magnolia Medical Technologies

• Sarah Huber has joined the company as Senior Vice President, Sales  (posted on February 13 2026).
• Dean Shute, Manager, Manufacturing Engineering, has left the company  (posted on January 30 2026).

Create your alert
to follow the executive moves at Magnolia Medical Technologies.

Magnolia Medical Technologies has 2,405 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Carl Gordon - Director at Odyssey Therapeutics

Learn more about the Biotechnology industry

Press releases by Magnolia Medical Technologies

• News & Media - Magnolia Medical
• Magnolia Medical Launches New Magnolia Analytics™ Service to Streamline Data Capture and Quantify the Clinical & Cost Effectiveness of Preventing Sepsis Misdiagnosis - Magnolia Medical
• News & Media - Magnolia Medical
• News & Media - Magnolia Medical
• In Recognition of Sepsis Awareness Month, Magnolia Medical Intensifies Efforts to Combat the Clinical and Economic Risks of Sepsis Misdiagnosis - Magnolia Medical
• Magnolia Medical Expands Steripath® Micro Initial Specimen Diversion Device® (ISDD®) Product Family with New FDA 510(k) Clearance - Magnolia Medical
• The National Quality Forum (NQF) Endorses Centers for Disease Control and Prevention’s (CDC) New Blood Culture Contamination Quality Measure Copy - Magnolia Medical
• The National Quality Forum (NQF) Endorses Centers for Disease Control and Prevention’s (CDC) New Blood Culture Contamination Quality Measure - Magnolia Medical
• Large-scale, peer-reviewed study quantifies multiple devastating patient harms associated with blood culture contamination and most significantly, a 74% increase in risk of in-hospital patient mortality - Magnolia Medical
• Stanford Health Care Achieves Zero Blood Culture Contaminations and Near Elimination of False-Positive CLABSIs in Large-Scale Study Using the Steripath® Initial Specimen Diversion Device® - Magnolia Medical
• View more press releases Close

Social media about Magnolia Medical Technologies

• Magnolia Medical Technologies on Wikipedia, Google News & Yahoo Finance
• Magnolia Medical Technologies on LinkedIn, X (Twitter) & YouTube